Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00437294
Status:
TERMINATED
Last Update Posted:
2020-08-10
First Post:
2007-02-16
Brief Title:
Enzastaurin in Combination of Capecitabine to Treat Breast Cancer
Sponsor:
Organization:
Eli Lilly and Company